Peptides have long been the unsung heroes of biochemistry, quietly orchestrating crucial functions within our bodies. These short chains of amino acids may not grab headlines like their larger protein counterparts, but their significance in biological processes is immense.

From signaling molecules that regulate various physiological functions to antimicrobial agents that fend off pathogens, peptides play diverse roles in our bodies. Moreover, their potential applications in medicine, such as peptide-based drugs and therapies, have garnered increasing attention from researchers and pharmaceutical companies alike.

Peptides have been around since the 1920s with the discovery of insulin. There has been a recent spotlight with the introduction of the now widely used glucagon like peptide (GLP-1) semaglutide (Ozempic & Wegovy) as well as the dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (Mounjaro and Zepbound).

However, the journey of peptides from lab bench to medicine cabinet isn't without its challenges. Regulatory hurdles, like the FDA ban, can sometimes impede progress. While such actions are often taken with the intention of ensuring safety and efficacy, they can also stifle innovation and limit access to potentially life-changing treatments.

Despite these obstacles, the field of peptide research continues to evolve rapidly. Advances in peptide synthesis, modification, and delivery methods are expanding the scope of their therapeutic applications. Additionally, growing interest in peptide engineering and design holds promise for developing novel peptide-based solutions to address unmet medical needs.

In essence, peptides may be small in size, but their impact on science and medicine looms large. As we navigate the complexities of regulation and innovation, it's crucial to recognize the invaluable contributions peptides make to our understanding of biology and our quest for improved healthcare.

To donate and help Dr. Edwin Lee fight for peptides to be taken off the FDA ban please follow this link: https://www.gofundme.com/f/save-peptides-from-the-fda?utm_campaign=p_lico+share-sheet-first-launch&utm_medium=copy_link&utm_source=customer

Semaglutide is a GLP-1 agonist that got FDA approval for weight loss in 2014. It is normally a peptide that is released by our intestine every time we eat to help regulate gastric emptying, insulin secretion and satiety.

It was first discovered in the venom of the Gila Monster Lizard which can go months without eating and ten years later it has completely revolutionized the weight loss world. Find out how it works, risks, benefits, contraindications and costs.

We offer an incredibly affordable weight loss program if your insurance does not cover this medication. Feel free to reach out to us at 310-325-9400 to find out how you can join.

Many women struggle with infertility and the demand for infertility services has grown substantially as the baby boom generation enters its reproductive age. The definition of infertility is the inability to conceive after 12 months of regular unprotective sex. Most pregnancies will occur in the first 6 menstrual cycles of attempted conception. The rates of infertility in the United States range from 12 to 18 percent. Primary infertility occurs in about 9% of nulliparous women ages 15-34, 25% of ages 35-39 and 30% in women ages 40-44. As you can see, the rates of infertility increase as you age.

Female factor infertility accounts for 37% of infertile couples while male factor infertility accounts for 8%. 5% of couples have unknown causes. This episode will explain some of the causes and the testing you need to get the answers you need.